MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
IMRX Immuneering
- 2.000
- +0.160+8.70%
Close Dec 20 16:00 ET
- 1.950
- -0.050-2.50%
Post 17:51 ET
62.10MMarket Cap-1.02P/E (TTM)
2.080High1.790Low680.05KVolume1.790Open1.840Pre Close1.34MTurnover3.04%Turnover RatioLossP/E (Static)31.05MShares7.92052wk High1.08P/B44.78MFloat Cap1.00052wk Low--Dividend TTM22.39MShs Float33.990Historical High--Div YieldTTM15.76%Amplitude1.000Historical Low1.964Avg Price1Lot Size
Immuneering Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 22, 2024
The average Immuneering stock price target is 11.50 with a max estimate of 15.00 and a min estimate of 8.00
Review Immuneering earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 22, 2024